WallStreetZenWallStreetZen

NYSE: ELV
Elevance Health Inc Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

ELV past earnings growth

How has ELV's earnings growth performed historically?
Company
0.23%
Industry
25.35%
Market
40.76%
ELV's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Industry Performance
ELV's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Market Performance
ELV's earnings growth is slowing... subscribe to Premium to read more.
Accelerating Earnings Growth Performance

ELV past revenue growth

How has ELV's revenue growth performed historically?
Company
10.03%
Industry
11.98%
Market
14.02%
ELV's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
ELV's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance
ELV's revenue growth is slowing... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

ELV earnings and revenue history

Current Revenue
$168.6B
Current Earnings
$6.1B
Current Profit Margin
3.6%
ELV's has demonstrated consistent long-term... subscribe to Premium to read more.
Long-term Earnings Growth Trend Performance

ELV Return on Equity

Current Company
16.2%
Current Industry
20.8%
Current Market
-8.4%
ELV's Return on Equity (16.2%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when ELV announces earnings.

ELV Return on Assets

Current Company
5.6%
Current Industry
6.3%
ELV is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

ELV Return on Capital Employed

Current Company
13.15%
Current Industry
14.9%
ELV has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

ELV vs Healthcare Plan Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
ELV$168.62B$10.62B$6.08B+13.03%+7.74%
CVS$347.81B$15.13B$8.60B+13.03%+16.95%
CI$189.90B$10.91B$5.30B+33.51%+9.51%
HUM$102.35B$5.22B$3.02B+12.85%+17.12%
CNC$150.10B$5.69B$2.44B+21.64%+12.79%
View Top Healthcare Plan Stocks

ELV earnings dates

Next earnings date
Jan 23, 2024

Elevance Health Earnings & Revenue FAQ

What were ELV's earnings last quarter?

On Invalid Date, Elevance Health (NYSE: ELV) reported Q3 2023 earnings per share (EPS) of $5.48, up 18.09% year over year. Total Elevance Health earnings for the quarter were $1.29 billion. In the same quarter last year, Elevance Health's earnings per share (EPS) was $6.69.

If you're new to stock investing, here's how to buy Elevance Health stock.

What was ELV's earnings growth in the past year?

As of Q4 2023, Elevance Health's earnings has grown 0.23% year over year. This is 25.12 percentage points lower than the US Healthcare Plans industry earnings growth rate of 25.35%. Elevance Health's earnings in the past year totalled $6.08 billion.

What is ELV's earnings date?

Elevance Health's earnings date is Invalid Date. Add ELV to your watchlist to be reminded of ELV's next earnings announcement.

What was ELV's revenue last quarter?

On Invalid Date, Elevance Health (NYSE: ELV) reported Q3 2023 revenue of $42.85 billion up 7.29% year over year. In the same quarter last year, Elevance Health's revenue was $39.94 billion.

What was ELV's revenue growth in the past year?

As of Q4 2023, Elevance Health's revenue has grown 10.03% year over year. This is 1.94 percentage points lower than the US Healthcare Plans industry revenue growth rate of 11.98%. Elevance Health's revenue in the past year totalled $168.62 billion.
©2023 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.